https://m2.mtmt.hu/ hun 2026-09-23 09:49 JournalArticle 35615425 VALIDATED true 0 false 2026-09-18T08:13:26.770+0000 2025-02-17T10:49:42.983+0000 2024-12-02T00:50:18.750+0000 true 10003491 Gonda Xénia /api/author/10003491 Author Gonda Xénia (Pszichiátria, pszichiátriai genetika, farmakológia, pszichofarmakológia, pszichoterápia, klinikai pszichológia, pszichológia) true 10003491 2025-07-28T10:06:54.968+0000 2025-02-17T10:49:43.140+0000 true 10080205 Szalóky-Siki Ágnes /api/admin/10080205 Admin Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Összefoglaló cikk (Folyóiratcikk) 102 true 1134514 true 1 /api/category/1 Category Tudományos true 1 Oliva, Vincenzo true true /api/journal/20089619 REVIEWED LANCET REGIONAL HEALTH - EUROPE 2666-7762 true false false 20089619 true 2666-7762 Journal FOREIGN 48 101135 101135 11 2025 true true 2024 true true true false true false GOLD 2026-09-18 false https://www.thelancet.com/journals/lanepe/home 140 0 140 115 1 138 140 128 137 138 138 113 113 115 25 0 140 115 140 115 0 4 4 Folyóiratcikk Journal Article 24 138 Könyvrészlet Chapter in Book 25 1 Könyv Book 23 1 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2025 0 44 31 44 31 2026 0 96 84 96 84 D1 false 10003491 false false false 2024-12-29T08:33:47.544+0000 NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport (SE / GYTK / GYHATAS); Pszichiátriai és Pszichoterápiás Klinika (SE / AOK / K) 1 23 2 6 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 121978113 /api/authorship/121978113 Oliva, Vincenzo 1 0.16666667 true false false Oliva Vincenzo true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 121978114 /api/authorship/121978114 Fico, Giovanna 2 0.16666667 false false false Fico Giovanna true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 121978115 /api/authorship/121978115 De Prisco, Michele 3 0.16666667 false false false De Prisco Michele true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 121978116 /api/authorship/121978116 Gonda, Xenia [Gonda, Xénia (Pszichiátria, psz...), szerző] NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport (SE / GYTK / GYHATAS); Pszichiátriai és Pszichoterápiás Klinika (SE / AOK / K) 4 0.167 false false false Author 10003491 /api/author/10003491 Gonda Xénia (Pszichiátria, pszichiátriai genetika, farmakológia, pszichofarmakológia, pszichoterápia, klinikai pszichológia, pszichológia) Gonda Xénia true 10003491 true Gonda Xenia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 121978117 /api/authorship/121978117 Rosa, Adriane R. 5 0.16666667 false false false Rosa Adriane R. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 121978118 /api/authorship/121978118 Vieta, Eduard ✉ 6 0.167 false true true Vieta Eduard true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 28048386 /api/publicationidentifier/28048386 DOI: 10.1016/j.lanepe.2024.101135 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/j.lanepe.2024.101135 https://doi.org/10.1016/j.lanepe.2024.101135 false true PublicationIdentifier 28413982 /api/publicationidentifier/28413982 WoS: 001409476500001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001409476500001 https://www.webofscience.com/wos/woscc/full-record/001409476500001 true true PublicationIdentifier 28133323 /api/publicationidentifier/28133323 Scopus: 85211752805 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85211752805 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85211752805 false true PublicationIdentifier 28413984 /api/publicationidentifier/28413984 PubMed: 39811787 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 39811787 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39811787&dopt=Abstract true true Classification 12317 /api/classification/12317 Pszichiátria true true SjrRating 11617772 /api/sjrrating/11617772 sjr:D1 (2025) Scopus - Public Health, Environmental and Occupational Health LANCET REGIONAL HEALTH - EUROPE 2666-7762 6 0.0 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2739 /api/classificationexternal/2739 Scopus - Public Health, Environmental and Occupational Health true 2739 true D1 DIRECT true true Reference 60375519 /api/reference/60375519 1. Merikangas 2011: Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative., Arch Gen Psychiatr, 68, p. 241, DOI: 10.1001/archgenpsychiatry.2011.12 1 10.1001/archgenpsychiatry.2011.12 false true Reference 60375520 /api/reference/60375520 2. Collaborators 2022: Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019., Lancet Psychiatr, 9, p. 137, DOI: 10.1016/S2215-0366(21)00395-3 2 10.1016/S2215-0366(21)00395-3 false true Reference 60375521 /api/reference/60375521 3. Mullins 2021: Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology., Nat Genet, 53, p. 817, DOI: 10.1038/s41588-021-00857-4 3 10.1038/s41588-021-00857-4 false true Reference 60375522 /api/reference/60375522 4. Lai 2024: Mapping the global, regional and national burden of bipolar disorder from 1990 to 2019: trend analysis on the Global Burden of Disease Study 2019., Br J Psychiatr, 224, p. 36, DOI: 10.1192/bjp.2023.127 4 10.1192/bjp.2023.127 false true Reference 60375523 /api/reference/60375523 5. 2024: Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021., Lancet, 403, p. 2204, DOI: 10.1016/S0140-6736(24)00685-8 5 10.1016/S0140-6736(24)00685-8 false true Reference 60375524 /api/reference/60375524 6. Bolton 2021: Bipolar disorder: trimodal age-at-onset distribution., Bipolar Disord, 23, p. 341, DOI: 10.1111/bdi.13016 6 10.1111/bdi.13016 false true Reference 60375525 /api/reference/60375525 7. Cloutier 2018: The economic burden of bipolar I disorder in the United States in 2015., J Affect Disord, 226, p. 45, DOI: 10.1016/j.jad.2017.09.011 7 10.1016/j.jad.2017.09.011 false true Reference 60375526 /api/reference/60375526 8. Simon 2021: The costs of bipolar disorder in the United Kingdom., Brain Behav, 11, DOI: 10.1002/brb3.2351 8 10.1002/brb3.2351 false true Reference 60375527 /api/reference/60375527 9. Laidi 2022: Direct medical cost of bipolar disorder: insights from the FACE-BD longitudinal cohort., J Affect Disord, 306, p. 223, DOI: 10.1016/j.jad.2022.02.071 9 10.1016/j.jad.2022.02.071 false true Reference 60375528 /api/reference/60375528 10. Dell'Osso 2021: Has Bipolar Disorder become a predominantly female gender related condition? Analysis of recently published large sample studies., Int J Bipolar Disord, 9, p. 3, DOI: 10.1186/s40345-020-00207-z 10 10.1186/s40345-020-00207-z false true Reference 60375529 /api/reference/60375529 11. Burt 2004: Special considerations in treating bipolar disorder in women., Bipolar Disord, 6, p. 2, DOI: 10.1046/j.1399-5618.2003.00089.x 11 10.1046/j.1399-5618.2003.00089.x false true Reference 60375530 /api/reference/60375530 12. Di Giacomo 2018: Estimating the risk of attempted suicide among sexual minority youths: a systematic review and meta-analysis., JAMA Pediatr, 172, p. 1145, DOI: 10.1001/jamapediatrics.2018.2731 12 10.1001/jamapediatrics.2018.2731 false true Reference 60375531 /api/reference/60375531 13. Abé 2018: Cortical brain structure and sexual orientation in adult females with bipolar disorder or attention deficit hyperactivity disorder., Brain Behav, 8, DOI: 10.1002/brb3.998 13 10.1002/brb3.998 false true Reference 60375532 /api/reference/60375532 14. Scott 2022: A systematic review and meta-analysis of delayed help-seeking, delayed diagnosis and duration of untreated illness in bipolar disorders., Acta Psychiatr Scand, 146, p. 389, DOI: 10.1111/acps.13490 14 10.1111/acps.13490 false true Reference 60375533 /api/reference/60375533 15. Vieta 2024: Cross-sectional studies: is pressing the pause button worth it in research?., Eur Neuropsychopharmacol, 85, p. 32, DOI: 10.1016/j.euroneuro.2024.06.005 15 10.1016/j.euroneuro.2024.06.005 false true Reference 60375534 /api/reference/60375534 16. Dong 2020: Prevalence of suicide attempts in bipolar disorder: a systematic review and meta-analysis of observational studies., Epidemiol Psychiatr Sci, 29, p. e63, DOI: 10.1017/S2045796019000593 16 10.1017/S2045796019000593 false true Reference 60375535 /api/reference/60375535 17. Tondo 2018: Characteristics of depressive and bipolar disorder patients with mixed features., Acta Psychiatr Scand, 138, p. 243, DOI: 10.1111/acps.12911 17 10.1111/acps.12911 false true Reference 60375536 /api/reference/60375536 18. Oliva 2022: Together is better: let's overcome the heterogeneity problem 18 false true Reference 60375537 /api/reference/60375537 19. Carvalho 2015: Treatment implications of predominant polarity and the polarity index: a comprehensive review., Int J Neuropsychopharmacol, 18, DOI: 10.1093/ijnp/pyu079 19 10.1093/ijnp/pyu079 false true Reference 60375538 /api/reference/60375538 20. Yatham 2010: The international society for bipolar disorders–battery for assessment of neurocognition (ISBD-BANC)., Bipolar Disord, 12, p. 351, DOI: 10.1111/j.1399-5618.2010.00830.x 20 10.1111/j.1399-5618.2010.00830.x false true Reference 60375539 /api/reference/60375539 21. Miskowiak 2019: Affective cognition in bipolar disorder: a systematic review by the ISBD targeting cognition task force., Bipolar Disord, 21, p. 686, DOI: 10.1111/bdi.12834 21 10.1111/bdi.12834 false true Reference 60375540 /api/reference/60375540 22. Oliva 2023: Correlation between emotion dysregulation and mood symptoms of bipolar disorder: a systematic review and meta-analysis., Acta Psychiatr Scand, 148, p. 472, DOI: 10.1111/acps.13618 22 10.1111/acps.13618 false true Reference 60375541 /api/reference/60375541 23. Léda-Rêgo 2024: Lifetime prevalence of psychiatric comorbidities in patients with bipolar disorder: a systematic review and meta-analysis., Psychiatr Res, 337, DOI: 10.1016/j.psychres.2024.115953 23 10.1016/j.psychres.2024.115953 false true Reference 60375542 /api/reference/60375542 24. Crump 2013: Comorbidities and mortality in bipolar disorder: a Swedish national cohort study., JAMA Psychiatr, 70, p. 931, DOI: 10.1001/jamapsychiatry.2013.1394 24 10.1001/jamapsychiatry.2013.1394 false true Reference 60375543 /api/reference/60375543 25. Goldstein 2015: Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American heart association., Circulation, 132, p. 965, DOI: 10.1161/CIR.0000000000000229 25 10.1161/CIR.0000000000000229 false true Reference 60375544 /api/reference/60375544 26. McGuffin 2003: The heritability of bipolar affective disorder and the genetic relationship to unipolar depression., Arch Gen Psychiatr, 60, p. 497, DOI: 10.1001/archpsyc.60.5.497 26 10.1001/archpsyc.60.5.497 false true Reference 60375545 /api/reference/60375545 27. Bortolato 2017: Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses., Bipolar Disord, 19, p. 84, DOI: 10.1111/bdi.12490 27 10.1111/bdi.12490 false true Reference 60375546 /api/reference/60375546 28. Fico 2021: Clinical correlates of seasonality in bipolar disorder: a specifier that needs specification?., Acta Psychiatr Scand, 143, p. 162, DOI: 10.1111/acps.13251 28 10.1111/acps.13251 false true Reference 60375547 /api/reference/60375547 29. Radua 2024: Impact of air pollution and climate change on mental health outcomes: an umbrella review of global evidence., World Psychiatr, 23, p. 244, DOI: 10.1002/wps.21219 29 10.1002/wps.21219 false true Reference 60375548 /api/reference/60375548 30. Fries 2016: The role of DNA methylation in the pathophysiology and treatment of bipolar disorder., Neurosci Biobehav Rev, 68, p. 474, DOI: 10.1016/j.neubiorev.2016.06.010 30 10.1016/j.neubiorev.2016.06.010 false true Reference 60375549 /api/reference/60375549 31. Zhu 2022: Cortical thickness abnormalities in patients with bipolar disorder: a systematic review and meta-analysis., J Affect Disord, 300, p. 209, DOI: 10.1016/j.jad.2021.12.080 31 10.1016/j.jad.2021.12.080 false true Reference 60375550 /api/reference/60375550 32. Ahmed 2023: Limbic and cortical regions as functional biomarkers associated with emotion regulation in bipolar disorder: a meta-analysis of neuroimaging studies., J Affect Disord, 323, p. 506, DOI: 10.1016/j.jad.2022.11.071 32 10.1016/j.jad.2022.11.071 false true Reference 60375551 /api/reference/60375551 33. Magioncalda 2022: A unified model of the pathophysiology of bipolar disorder., Mol Psychiatr, 27, p. 202, DOI: 10.1038/s41380-021-01091-4 33 10.1038/s41380-021-01091-4 false true Reference 60375552 /api/reference/60375552 34. Giménez-Palomo 2024: Reduced mitochondrial respiratory capacity in patients with acute episodes of bipolar disorder: could bipolar disorder be a state-dependent mitochondrial disease?., Acta Psychiatr Scand, 149, p. 52, DOI: 10.1111/acps.13635 34 10.1111/acps.13635 false true Reference 60375553 /api/reference/60375553 35. Poletti 2024: Inflammatory mediators in major depression and bipolar disorder., Transl Psychiatry, 14, p. 247, DOI: 10.1038/s41398-024-02921-z 35 10.1038/s41398-024-02921-z false true Reference 60375554 /api/reference/60375554 36. Weiss 2015: Kindling of life stress in bipolar disorder: comparison of sensitization and autonomy models., J Abnorm Psychol, 124, p. 4, DOI: 10.1037/abn0000014 36 10.1037/abn0000014 false true Reference 60375555 /api/reference/60375555 37. Lorenzon 2024: Diving into the precision psychiatry debate: how deep can we go?., Eur Neuropsychopharmacol, 84, p. 57, DOI: 10.1016/j.euroneuro.2024.02.001 37 10.1016/j.euroneuro.2024.02.001 false true Reference 60375556 /api/reference/60375556 38. Carvalho 2020: Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders., Transl Psychiatry, 10, p. 152, DOI: 10.1038/s41398-020-0835-5 38 10.1038/s41398-020-0835-5 false true Reference 60375557 /api/reference/60375557 39. Fico 2024: Antidepressant use in bipolar disorder: shifting focus from'Whether'to'Whom'., Eur Neuropsychopharmacol, 84, p. 1, DOI: 10.1016/j.euroneuro.2024.04.004 39 10.1016/j.euroneuro.2024.04.004 false true Reference 60375558 /api/reference/60375558 40. Yildiz 2023: Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis., Lancet Psychiatr, 10, p. 693, DOI: 10.1016/S2215-0366(23)00199-2 40 10.1016/S2215-0366(23)00199-2 false true Reference 60375559 /api/reference/60375559 41. Hong 2022: A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years., Psychopharmacology, 239, p. 3367, DOI: 10.1007/s00213-022-06230-5 41 10.1007/s00213-022-06230-5 false true Reference 60375560 /api/reference/60375560 42. Kishi 2021: Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials., Mol Psychiatr, 26, p. 4146, DOI: 10.1038/s41380-020-00946-6 42 10.1038/s41380-020-00946-6 false true Reference 60375561 /api/reference/60375561 43. Oliva 2024: Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis., Lancet Psychiatr, 11, p. 210, DOI: 10.1016/S2215-0366(24)00006-3 43 10.1016/S2215-0366(24)00006-3 false true Reference 60375562 /api/reference/60375562 44. Goodwin 2016: Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology., J Psychopharmacol, 30, p. 495, DOI: 10.1177/0269881116636545 44 10.1177/0269881116636545 false true Reference 60375563 /api/reference/60375563 45. Yatham 2018: Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder., Bipolar Disord, 20, p. 97, DOI: 10.1111/bdi.12609 45 10.1111/bdi.12609 false true Reference 60375564 /api/reference/60375564 46. Fountoulakis 2017: The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines., Int J Neuropsychopharmacol, 20, p. 180 46 false true Reference 60375565 /api/reference/60375565 47. Kendall 2016: NICE guidance on psychological treatments for bipolar disorder., Lancet Psychiatr, 3, p. 317, DOI: 10.1016/S2215-0366(16)00082-1 47 10.1016/S2215-0366(16)00082-1 false true Reference 60375566 /api/reference/60375566 48. Malhi 2021: The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders., Aust N Z J Psychiatr, 55, p. 7, DOI: 10.1177/0004867420979353 48 10.1177/0004867420979353 false true Reference 60375567 /api/reference/60375567 49. Grunze 2013: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder., World J Biol Psychiatr, 14, p. 154, DOI: 10.3109/15622975.2013.770551 49 10.3109/15622975.2013.770551 false true Reference 60375568 /api/reference/60375568 50. Miller 2014: The prevalence and burden of bipolar depression., J Affect Disord, 169, p. S3, DOI: 10.1016/S0165-0327(14)70003-5 50 10.1016/S0165-0327(14)70003-5 false true Reference 60375569 /api/reference/60375569 51. Kessing 2016: Nationwide and population-based prescription patterns in bipolar disorder., Bipolar Disord, 18, p. 174, DOI: 10.1111/bdi.12371 51 10.1111/bdi.12371 false true Reference 60375570 /api/reference/60375570 52. Wong 2018: Exclusion criteria and generalizability in bipolar disorder treatment trials., Contemp Clin Trials Commun, 9, p. 130, DOI: 10.1016/j.conctc.2018.01.009 52 10.1016/j.conctc.2018.01.009 false true Reference 60375571 /api/reference/60375571 53. Gribkoff 2017: The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes., Neuropharmacology, 120, p. 11, DOI: 10.1016/j.neuropharm.2016.03.021 53 10.1016/j.neuropharm.2016.03.021 false true Reference 60375572 /api/reference/60375572 54. Pacchiarotti 2013: The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders., Am J Psychiatr, 170, p. 1249, DOI: 10.1176/appi.ajp.2013.13020185 54 10.1176/appi.ajp.2013.13020185 false true Reference 60375573 /api/reference/60375573 55. Elsayed 2022: Treatment-resistant bipolar depression: therapeutic trends, challenges and future directions., Neuropsychiatr Dis Treat, 18, p. 2927, DOI: 10.2147/NDT.S273503 55 10.2147/NDT.S273503 false true Reference 60375574 /api/reference/60375574 56. Fountoulakis 2020: The CINP guidelines on the definition and evidence-based interventions for treatment-resistant bipolar disorder., Int J Neuropsychopharmacol, 23, p. 230, DOI: 10.1093/ijnp/pyz064 56 10.1093/ijnp/pyz064 false true Reference 60375575 /api/reference/60375575 57. Dell'Osso 2023: Exploring the potential of Esketamine in the treatment of bipolar depression., Eur Neuropsychopharmacol, 77, p. 21, DOI: 10.1016/j.euroneuro.2023.08.498 57 10.1016/j.euroneuro.2023.08.498 false true Reference 60375576 /api/reference/60375576 58. Bahji 2019: ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression., Acta Psychiatr Scand, 139, p. 214, DOI: 10.1111/acps.12994 58 10.1111/acps.12994 false true Reference 60375577 /api/reference/60375577 59. Verdijk 2022: Pharmacological interventions to diminish cognitive side effects of electroconvulsive therapy: a systematic review and meta-analysis., Acta Psychiatr Scand, 145, p. 343, DOI: 10.1111/acps.13397 59 10.1111/acps.13397 false true Reference 60375578 /api/reference/60375578 60. Chen 2021: Effect of pharmacological and neurostimulation interventions for cognitive domains in patients with bipolar disorder: a systematic review and network meta-analysis of randomized controlled trials., Clin Epidemiol, p. 1039, DOI: 10.2147/CLEP.S335584 60 10.2147/CLEP.S335584 false true Reference 60375579 /api/reference/60375579 61. Kozicky 2016: Neuroprogression and episode recurrence in bipolar I disorder: a study of gray matter volume changes in first-episode mania and association with clinical outcome., Bipolar Disord, 18, p. 511, DOI: 10.1111/bdi.12437 61 10.1111/bdi.12437 false true Reference 60375580 /api/reference/60375580 62. Kessing 2010: Does lithium protect against dementia?., Bipolar Disord, 12, p. 87, DOI: 10.1111/j.1399-5618.2009.00788.x 62 10.1111/j.1399-5618.2009.00788.x false true Reference 60375581 /api/reference/60375581 63. Yatham 2023: Duration of adjunctive antidepressant maintenance in bipolar I depression., N Engl J Med, 389, p. 430, DOI: 10.1056/NEJMoa2300184 63 10.1056/NEJMoa2300184 false true Reference 60375582 /api/reference/60375582 64. Vieta 2018: Bipolar disorders., Nat Rev Dis Prim, 4, p. 1 64 false true Reference 60375583 /api/reference/60375583 65. Anmella 2023: Teratogenicity of valproate: further reasons for action., Eur Neuropsychopharmacol, 80, p. 25, DOI: 10.1016/j.euroneuro.2023.11.008 65 10.1016/j.euroneuro.2023.11.008 false true Reference 60375584 /api/reference/60375584 66. Lingam 2002: Treatment non-adherence in affective disorders., Acta Psychiatr Scand, 105, p. 164, DOI: 10.1034/j.1600-0447.2002.1r084.x 66 10.1034/j.1600-0447.2002.1r084.x false true Reference 60375585 /api/reference/60375585 67. Chatterton 2017: Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis., Br J Psychiatry, 210, p. 333, DOI: 10.1192/bjp.bp.116.195321 67 10.1192/bjp.bp.116.195321 false true Reference 60375586 /api/reference/60375586 68. Miklowitz 2021: Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis., JAMA Psychiatr, 78, p. 141, DOI: 10.1001/jamapsychiatry.2020.2993 68 10.1001/jamapsychiatry.2020.2993 false true Reference 60375587 /api/reference/60375587 69. Salvetat 2022: A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers., Transl Psychiatry, 12, p. 182, DOI: 10.1038/s41398-022-01938-6 69 10.1038/s41398-022-01938-6 false true Reference 60375588 /api/reference/60375588 70. Gadad 2018: Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks., J Affect Disord, 233, p. 3, DOI: 10.1016/j.jad.2017.07.001 70 10.1016/j.jad.2017.07.001 false true Reference 60375589 /api/reference/60375589 71. Anmella 2024: Automated speech analysis in bipolar disorder: the CALIBER study protocol and preliminary results., J Clin Med, 13, p. 4997 71 false true Reference 60375590 /api/reference/60375590 72. Perra 2023: A recovery-oriented program for people with bipolar disorder through virtual reality-based cognitive remediation: results of a feasibility randomized clinical trial., J Clin Med, 12, p. 2142 72 false true Reference 60375591 /api/reference/60375591 73. Rosenblat 2024: Psilocybin-assisted psychotherapy for treatment resistant depression: a randomized clinical trial evaluating repeated doses of psilocybin., Med, 5, p. 190, DOI: 10.1016/j.medj.2024.01.005 73 10.1016/j.medj.2024.01.005 false true Reference 60375592 /api/reference/60375592 74. McCaffrey 2021: The muscarinic-cholinergic system as a target in the treatment of depressive or manic episodes in bipolar disorder: a systematic review and meta-analysis., J Affect Disord Rep, 6 74 false true Reference 60375593 /api/reference/60375593 75. Anmella 2023: Exploring digital biomarkers of illness activity in mood episodes: hypotheses generating and model development study., JMIR mHealth and uHealth, 11 75 false true Reference 60375594 /api/reference/60375594 76. Di Passa 2024: Clinical efficacy of deep transcranial magnetic stimulation (dTMS) in psychiatric and cognitive disorders: a systematic review., J Psychiatr Res, 175, p. 287, DOI: 10.1016/j.jpsychires.2024.05.011 76 10.1016/j.jpsychires.2024.05.011 false true Reference 60375595 /api/reference/60375595 77. Hsu 2024: Comparing different non-invasive brain stimulation interventions for bipolar depression treatment: a network meta-analysis of randomized controlled trials., Neurosci Biobehav Rev, 156, DOI: 10.1016/j.neubiorev.2023.105483 77 10.1016/j.neubiorev.2023.105483 false true /api/publication/35615425 Oliva Vincenzo et al. Bipolar disorders: an update on critical aspects. (2025) LANCET REGIONAL HEALTH - EUROPE 2666-7762 48<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Oliva Vincenzo </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Fico Giovanna </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >De Prisco Michele </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10003491"><a href="/gui2/?type=authors&mode=browse&sel=10003491" target="_blank">Gonda Xenia (<span class="authorship-author-name">Gonda Xénia</span> <span class="authorAux-mtmt"> Pszichiátria, pszichiátriai genetika, farmakoló...</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Gyógyszerésztudományi Kar">GYTK</span>/<span title="Gyógyszerhatástani Intézet">GYHATAS</span>/NAP3.0-SE Neuropszichofarmakológiai Kutatócsoport; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Pszichiátriai és Pszichoterápiás Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Rosa Adriane R. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Vieta Eduard ✉ </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;35615425" target="_blank">Bipolar disorders: an update on critical aspects</a></div> <div> <span class="journal-title">LANCET REGIONAL HEALTH - EUROPE</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2666-7762">2666-7762</a>)</span>: <span class="journal-volume">48</span> <span class="page"> Paper 101135. 11 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/j.lanepe.2024.101135" target="_blank" href="https://doi.org/10.1016/j.lanepe.2024.101135"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001409476500001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001409476500001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85211752805" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85211752805"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="39811787" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=39811787&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Health Policy&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Internal Medicine&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Oncology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Public Health, Environmental and Occupational Health&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 140</span> | Független: 115 | Függő: 25 | Nem jelölt: 0 | WoS jelölt: 128 | Scopus jelölt:&nbsp;137 | WoS/Scopus jelölt:&nbsp;138 | DOI jelölt:&nbsp;140 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;35615425&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 4 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 35615425</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Összefoglaló cikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2025.02.17. 11:49 Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) </div> </div></div>